NASDAQ:TTOO

T2 Biosystems Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy TTOO

*Your capital is at risk

$0.0004

-0.0001 (-20.00%)

At Close: Jun 22, 2026

T2 Biosystems Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.85. In total, the insiders bought 2.38B and sold 22.21M TTOO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	99.85
● Buy	2.38B shares
● Sell	22.21M shares
88% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jun 12, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 99.85. Confidence increased due to high data reliability score of 90. Supported by overwhelming buy-side pressure (88% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 09, 2024 Sell	Series B Preferred Stock C-Conversion	Cr Group L.p. 10 Percent Owner	10% Owner	10 875 Value: $0
May 09, 2024 Sell	Series B Preferred Stock C-Conversion	Cr Group L.p. 10 Percent Owner	10% Owner	10 875 Value: $0
May 09, 2024 Sell	Series A Preferred Stock C-Conversion	Cr Group L.p. 10 Percent Owner	10% Owner	17 160 Value: $0
May 09, 2024 Buy	Common Stock C-Conversion	Cr Group L.p. 10 Percent Owner	10% Owner	1 716 048 Value: $0
May 09, 2024 Buy	Common Stock C-Conversion	Cr Group L.p. 10 Percent Owner	10% Owner	108 752 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	1 565 445 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	2 001 514 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	648 139 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	403 608 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	129 629 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	129 629 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	403 608 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	648 139 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	2 001 514 Value: $0
May 03, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	1 565 445 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	1 647 315 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	390 142 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	682 036 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	424 716 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	136 409 Value: $0
Apr 12, 2024 Buy	Series A Convertible Preferred Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	17 160 Value: $0
Apr 12, 2024 Buy	Series A Convertible Preferred Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	17 160 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	136 409 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	424 716 Value: $0
Apr 12, 2024 Buy	Common Stock A-Award	Cr Group L.p. 10 Percent Owner	10% Owner	682 036 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT T2 BIOSYSTEMS

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagn...

Read Full Profile Here